Recent studies have demonstrated that the expression level of SLAMF1 is significantly increased in liver tissue of NASH compared with non-NASH controls and that the level of SLAMF1 was dramatically related to the seriousness of the NASH phenotype. The gene discussed is SLAMF1; the disease is metabolic dysfunction-associated steatohepatitis.